Proteasome allostery as a population shift between interchanging conformers
暂无分享,去创建一个
[1] A. Goldberg,et al. Preparation of hybrid (19S-20S-PA28) proteasome complexes and analysis of peptides generated during protein degradation. , 2005, Methods in enzymology.
[2] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[3] L. Kay,et al. Probing supramolecular structure from measurement of methyl (1)H-(13)C residual dipolar couplings. , 2007, Journal of the American Chemical Society.
[4] L. Kay,et al. Dynamic Regulation of Archaeal Proteasome Gate Opening As Studied by TROSY NMR , 2010, Science.
[5] S. Ōmura,et al. Potential Immunocompetence of Proteolytic Fragments Produced by Proteasomes before Evolution of the Vertebrate Immune System , 1997, The Journal of experimental medicine.
[6] R. Dohmen,et al. Catalytic mechanism and assembly of the proteasome. , 2009, Chemical reviews.
[7] M. Groll,et al. 20S proteasome and its inhibitors: crystallographic knowledge for drug development. , 2007, Chemical reviews.
[8] R. Huber,et al. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. , 1995, Science.
[9] L. Kay,et al. Cross-correlated relaxation enhanced 1H[bond]13C NMR spectroscopy of methyl groups in very high molecular weight proteins and protein complexes. , 2003, Journal of the American Chemical Society.
[10] A. Bax. Weak alignment offers new NMR opportunities to study protein structure and dynamics , 2003, Protein science : a publication of the Protein Society.
[11] M. Glickman,et al. Stability of the proteasome can be regulated allosterically through engagement of its proteolytic active sites , 2007, Nature Structural &Molecular Biology.
[12] A. Goldberg,et al. Protein degradation and the generation of MHC class I-presented peptides. , 2002, Advances in immunology.
[13] H. Holzhütter,et al. Evidence for the Existence of a Non-catalytic Modifier Site of Peptide Hydrolysis by the 20 S Proteasome* , 2000, The Journal of Biological Chemistry.
[14] L. Kay,et al. Effect of noncompetitive proteasome inhibition on bortezomib resistance. , 2010, Journal of the National Cancer Institute.
[15] K. Ferrell,et al. Structural Models for Interactions between the 20S Proteasome and Its PAN/19S Activators* , 2009, The Journal of Biological Chemistry.
[16] L. Masterson,et al. cAMP-dependent protein kinase A selects the excited state of the membrane substrate phospholamban. , 2011, Journal of molecular biology.
[17] Lila M. Gierasch,et al. Allosteric signal transmission in the nucleotide-binding domain of 70-kDa heat shock protein (Hsp70) molecular chaperones , 2011, Proceedings of the National Academy of Sciences.
[18] S. Chatterjee,et al. Applications of saturation transfer difference NMR in biological systems. , 2012, Drug discovery today.
[19] Giuseppe Melacini,et al. Mapping allostery through the covariance analysis of NMR chemical shifts , 2011, Proceedings of the National Academy of Sciences.
[20] Yifan Cheng,et al. Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases. , 2008, Molecular cell.
[21] M. Bogyo,et al. Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta. , 2001, EMBO Journal.
[22] Yifan Cheng. Toward an atomic model of the 26S proteasome. , 2009, Current opinion in structural biology.
[23] K. Lindsten,et al. Lack of proteasome active site allostery as revealed by subunit-specific inhibitors. , 2001, Molecular cell.
[24] Keiji Tanaka,et al. Double‐cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region , 1997, Genes to cells : devoted to molecular & cellular mechanisms.
[25] K. Sadre-Bazzaz,et al. Structure of a Blm10 complex reveals common mechanisms for proteasome binding and gate opening. , 2010, Molecular cell.
[26] C. Hill,et al. Purification and analysis of recombinant 11S activators of the 20S proteasome: Trypanosoma brucei PA26 and human PA28 alpha, PA28 beta, and PA28 gamma. , 2005, Methods in enzymology.
[27] C. Hill,et al. Proteasome activators. , 2011, Molecular cell.
[28] M. Groll,et al. Exploiting nature's rich source of proteasome inhibitors as starting points in drug development. , 2012, Chemical communications.
[29] M. Bogyo,et al. Lysine 188 substitutions convert the pattern of proteasome activation by REGγ to that of REGs α and β , 2001 .
[30] L. Kay,et al. The proteasome antechamber maintains substrates in an unfolded state , 2010, Nature.
[31] D E Wemmer,et al. Two-state allosteric behavior in a single-domain signaling protein. , 2001, Science.
[32] Yifan Cheng,et al. Interactions of PAN's C‐termini with archaeal 20S proteasome and implications for the eukaryotic proteasome–ATPase interactions , 2010, The EMBO journal.
[33] M. Hochstrasser,et al. A tetrahedral transition state at the active sites of the 20S proteasome is coupled to opening of the alpha-ring channel. , 2009, Structure.
[34] R. Huber,et al. Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.
[35] B. Meyer,et al. Direct observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectroscopy method shows a significantly higher affinity of integrin alpha(IIb)beta3 in native platelets than in liposomes. , 2005, Journal of the American Chemical Society.
[36] Lewis E. Kay,et al. Quantitative dynamics and binding studies of the 20S proteasome by NMR , 2007, Nature.
[37] C. Hill,et al. The 1.9 A structure of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 interactions. , 2005, Molecules and Cells.
[38] M. Rechsteiner,et al. The proteasome activator 11 S REG (PA28) and class I antigen presentation. , 2000, The Biochemical journal.
[39] W Keilholz,et al. Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[40] Soyeon Park,et al. Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry. , 2007, Molecular cell.
[41] M. Rechsteiner,et al. Substrate specificity of the human proteasome. , 2001, Chemistry & biology.
[42] S. Tzeng,et al. Protein activity regulation by conformational entropy , 2012, Nature.
[43] L. Kay,et al. Novel proteasome inhibitors to overcome bortezomib resistance. , 2011, Journal of the National Cancer Institute.
[44] G. Amarasinghe,et al. Internal dynamics control activation and activity of the autoinhibited Vav DH domain , 2008, Nature Structural &Molecular Biology.
[45] L. Kay,et al. Solution NMR of supramolecular complexes: providing new insights into function , 2007, Nature Methods.
[46] L. Kay,et al. TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors. , 2008, Biochemistry.
[47] P. Osmulski,et al. Nanoenzymology of the 20S proteasome: proteasomal actions are controlled by the allosteric transition. , 2002, Biochemistry.
[48] Hans-Georg Rammensee,et al. Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.
[49] J. Cavanagh. Protein NMR Spectroscopy: Principles and Practice , 1995 .
[50] M. Hochstrasser,et al. A Conserved 20S Proteasome Assembly Factor Requires a C-terminal HbYX Motif for Proteasomal Precursor Binding , 2011, Nature Structural &Molecular Biology.
[51] L. Kay,et al. Isotope labeling strategies for the study of high-molecular-weight proteins by solution NMR spectroscopy , 2006, Nature Protocols.